[Table/Fig-5]:
CD66c expression according to clinicopathologic parameters in CRC patients.
| Variables | CD66c Immunohistochemistry | |||||||
|---|---|---|---|---|---|---|---|---|
| Total | Neg-ative | <50% | 51-80% | >81% | Chi-square | p- value |
||
| Sex | Male | 15 | 7 | 6 | 2 | 0 | 1.489 | 0.552 |
| Female | 11 | 7 | 2 | 2 | 0 | |||
| Age | 20-40years | 4 | 3 | 1 | 0 | 0 | 2.119 | 0.713 |
| 40-60years | 14 | 8 | 4 | 2 | 0 | |||
| >60years | 8 | 3 | 4 | 1 | 0 | |||
| TNM staging | Stage-I | 6 | 4 | 1 | 1 | 0 | 1.541 | 0.947 |
| Stage-II | 10 | 5 | 3 | 2 | 0 | |||
| Stage -III | 10 | 5 | 4 | 1 | 0 | |||
| Duke staging | A | 6 | 3 | 2 | 1 | 0 | 1.541 | 0.947 |
| B | 10 | 6 | 2 | 2 | 0 | |||
| C | 10 | 5 | 4 | 1 | 0 | |||
| Tumour site | Colon | 11 | 2 | 5 | 4 | 0 | 11.63 | 0.02 |
| Rectum | 12 | 10 | 2 | 0 | 0 | |||
| Rectosigmoidal | 3 | 2 | 1 | 0 | 0 | |||
| Tumour grade | Well differentiated | 2 | 1 | 0 | 1 | 0 | 5.149 | 0.263 |
| Moderately differentiated | 22 | 12 | 8 | 2 | 0 | |||
| Poorly differentiated | 2 | 1 | 0 | 1 | 0 | |||
Foot Note: Chi-square / Fisher’s-exact test